FDA weighs lifting safety restrictions on Avandia 06/03/2013 majac Your Health Matters WASHINGTON (AP) — A former blockbuster diabetes pill that was subjected to major safety restrictions in 2010 may be less risky than once thought, according to the latest analysis of the much-debated GlaxoSmithKline drug Avandia. Share on FacebookTweetFollow usSave